[Budget impact analysis of idarucizumab for the management of patients treated with dabigatran in emergency / urgent situations in Italy]. FE [Internet]. 2016 Jun. 28 [cited 2025 Oct. 29];17(2):47-58. Available from: https://journals.seedstm.com/index.php/FE/article/view/1243